Teton Advisors Inc. Has $485,000 Holdings in Cutera, Inc. (NASDAQ:CUTR)

Teton Advisors Inc. cut its position in Cutera, Inc. (NASDAQ:CUTR) by 28.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 137,660 shares of the medical device company’s stock after selling 53,500 shares during the quarter. Teton Advisors Inc. owned about 0.69% of Cutera worth $485,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Tower Research Capital LLC TRC boosted its position in Cutera by 112.6% during the fourth quarter. Tower Research Capital LLC TRC now owns 8,363 shares of the medical device company’s stock worth $29,000 after purchasing an additional 4,430 shares during the period. Dynamic Technology Lab Private Ltd bought a new position in Cutera during the fourth quarter worth $102,000. Federated Hermes Inc. boosted its position in Cutera by 38.8% during the fourth quarter. Federated Hermes Inc. now owns 148,559 shares of the medical device company’s stock worth $524,000 after purchasing an additional 41,500 shares during the period. SG Americas Securities LLC bought a new position in Cutera during the fourth quarter worth $43,000. Finally, Public Employees Retirement System of Ohio bought a new position in Cutera during the third quarter worth $43,000. 90.70% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Stephens reaffirmed an “overweight” rating and set a $10.00 price objective on shares of Cutera in a research report on Friday, March 22nd. William Blair raised shares of Cutera from an “underperform” rating to a “market perform” rating in a research report on Friday, March 22nd. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Cutera currently has a consensus rating of “Hold” and a consensus target price of $14.75.

Cutera Stock Up 4.9 %

Shares of Cutera stock traded up $0.12 during trading on Thursday, reaching $2.57. The company’s stock had a trading volume of 598,940 shares, compared to its average volume of 1,597,042. The business’s 50-day moving average price is $1.98 and its 200-day moving average price is $2.57. The firm has a market cap of $51.25 million, a PE ratio of -0.34 and a beta of 1.43. Cutera, Inc. has a 52 week low of $1.28 and a 52 week high of $21.93.

Cutera (NASDAQ:CUTR) last announced its earnings results on Thursday, March 21st. The medical device company reported ($2.27) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.20) by ($1.07). The firm had revenue of $49.54 million for the quarter, compared to the consensus estimate of $49.10 million. Equities analysts predict that Cutera, Inc. will post -5.88 earnings per share for the current year.

Cutera Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform.